Thank you Buildit for the great analysis which is also very

New Post Public Reply Private Reply Replies (0) Message Board
Paul Jackson Buildit #14797
459
Thank you Buildit for the great analysis which is also very entertaining! haha...

I think as soon as GNBT has some solid contracts and get the S1 funding, then whatever you are saying may come true...

I am wondering if we have found the peptide and will see $5 million from China soon... the China contract was signed on March 2....more than 3 weeks ago...


______________


Weekend discussion:

Most of you know I'm about as bullish on GNBT as they come. However, that voice inside of me that says, "Hope is not a strategy" keeps popping into my head.

I'm sure some of you have had similar thoughts. So, in all seriousness, please poke giant holes in the simple analysis of the NGIO spin I am about to post... since I continue to feel skepticism building as the clock ticks on, and NGIO is one of the very few levers we have to pull at this point.

(Note: Some numbers are being rounded for simplicity, but they are not materially different from reality.)
______________________________


Step 1: Let's say I'm a wealthy investor or a fund manager that met Joe at the Wainwright conference, and I've taken a deep dive into NGIO. I'm very convinced that NGIO has a great team and great IP, and I'd like to invest a good chunk of change. I decide to meet with the investment bank with the goal of buying 10MM shares thru the IPO.


Step 2: My meeting with the bankers provides me with the following information:

There will be 400MM shares of NGIO. GNBT shareholders hold approximately 40MM, Joe is keeping 280MM shares for GNBT, and that leaves 80MM for the IPO.

Let's assume the spin price is $4/share to get NGIO directly to the Naz. So I can buy the 10MM shares I want for $40MM thru the IPO and acquire a 2.5% holding of NGIO.

My team and I do some analysis. "That sounds like a worthy investment", I think to myself!


Step 3: One of my minions at the office comes to me with the following analysis, after doing some further DD on Generex and its NGIO holdings...

"Hey, boss... There are 80MM shares of GNBT outstanding. GNBT will own 280MM shares of NGIO after the spin. So, indirectly, each share of GNBT will "own" ~3.5 shares of NGIO.

So instead of buying 10MM shares for $40MM thru the IPO, let's buy shares of GNBT right now on the open market. It's currently trading for about 50 cents!

We could start buying now, before the IPO. Even if the upward pressure of our buying pushes up the price, we could probably buy 4MM shares at an average price of $2. That would cost $8MM, and we would effectively "own" 12.5MM shares of NGIO (3.5 x 4MM), indirectly giving us a larger stake (3.125%) for 20% of the cost of doing it thru the IPO.

PLUS, we'd have about 5% ownership in Generex... and just look at all the irons they have in the fire!"


Step 4: I give my minion a raise and begin to buy GNBT shares the next trading day.


_______________________________

Holes I see in my argument:

1) GNBT is not on a major exchange, so many of these theoretical buyers are not allowed thru their entities to buy GNBT shares.

2) A larger entity may not want to get mixed up with GNBT and all of its dirty laundry, so they are not interested in this approach and would prefer to buy the "clean" shares of NGIO.

3) Nobody knows about this tiny little OTC company. (I'll refute this point right now, as any of the prospective participants in the IPO certainly know a lot about this little company if they are considering buying into this IPO.)


Is that it? Are those the only barriers that keep an upcoming spinoff that is implied at a $1.6B value (400MM x $4) from telegraphing any value to GNBT shares right now? If I had oodles of money to invest and believed Joe's story, would I not find a way to go thru GNBT ownership instead of getting run thru the price wringer with the NGIO IPO?


Again, please show me what I'm missing here.
Thanks, and have a great weekend!

Read More: https://investorshangout.com/post/newpost/622...z6Hx3dq0DK

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 13

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 6

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 5

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 3

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 6

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading

Top 5 Most Recently Viewed Articles

SaverOne Adjusts Share Ratio to Align with Nasdaq Standards

Updated Category News Views 267

SaverOne Adjusts Share Ratio to Align with Nasdaq Standards SaverOne 2014 Ltd. (NASDAQ: SVRE) has recently implemented a significant adjustment to its share ratio to meet compliance with the Nasdaq's strict listing requirements. This strategic move comes after the company faced challenges due to its stock price breaching the minimum bid price set by Nasdaq. Navigating...

Continue Reading
BridgeBio Announces Upcoming Investor Engagements for Growth

Updated Category News Views 244

BridgeBio Pharma's Participation in Investor Conferences BridgeBio Pharma, Inc. (NASDAQ: BBIO) is set to actively engage with investors in November, taking part in prominent healthcare investor conferences. These events represent a significant opportunity for the company to share its advancements in treating genetic diseases and connect with stakeholders in the healthcare...

Continue Reading
Tesla's Earnings Report: A Critical Moment for Investors

Updated Category News Views 155

An Overview of Tesla's Market Position Shares of Tesla Inc. are approaching their next earnings report amid increasing tension and scrutiny. Following a seven-day losing streak at the close of 2025, the stock has been trying to stabilize at its rising support line. This price action indicates a potential higher low in the ongoing rally since last summer, which could be...

Continue Reading
Rumble Prepares for Third Quarter Earnings Announcement

Updated Category News Views 218

Rumble's Upcoming Third Quarter Earnings Release Rumble Inc. (NASDAQ: RUM) is gearing up for an important financial milestone by announcing the release of its earnings report for the fiscal quarter that ended recently. This event is scheduled to take place after the market closes on a Tuesday in the near future. The company has positioned itself as a significant player in...

Continue Reading
Investigation Launched for Fly-E Group, Inc. Investors

Updated Category News Views 184

Investigation Initiated for Fly-E Group, Inc. Investors Glancy Prongay & Murray LLP, a renowned national shareholder rights law firm, has announced an investigation on behalf of Fly-E Group, Inc. (FLYE) investors. This inquiry centers around potential violations of federal securities laws by the company. Notable Recent Events Affecting Fly-E Recently, Fly-E faced serious...

Continue Reading